Tempus AI, Inc. (NASDAQ:TEM) EVP Erik Phelps Sells 61,582 Shares

Tempus AI, Inc. (NASDAQ:TEM) EVP Erik Phelps sold 61,582 shares of the stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $82.36, for a total transaction of $5,071,893.52. Following the completion of the sale, the executive vice president now owns 153,080 shares of the company’s stock, valued at approximately $12,607,668.80. The trade was a 28.69 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Erik Phelps also recently made the following trade(s):

• On Wednesday, February 5th, Erik Phelps sold 5,934 shares of Tempus AI stock. The shares were sold at an average price of $67.57, for a total transaction of $400,960.38.

Tempus AI Trading Down 11.2 %

Shares of Tempus AI stock opened at $68.09 on Friday. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The firm has a 50 day simple moving average of $50.29 and a 200 day simple moving average of $51.65. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $91.45.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Needham & Company LLC reissued a “buy” rating and issued a $56.00 price target on shares of Tempus AI in a research report on Tuesday, January 14th. William Blair lowered shares of Tempus AI from an “outperform” rating to a “market perform” rating in a research report on Wednesday, February 12th. Guggenheim assumed coverage on shares of Tempus AI in a research report on Monday, December 9th. They issued a “buy” rating and a $74.00 price target for the company. Bank of America increased their price target on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research report on Friday, December 13th. Finally, Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and raised their price objective for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $58.55.

Institutional Trading of Tempus AI

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Wells Fargo & Company MN increased its holdings in shares of Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock valued at $80,000 after purchasing an additional 278 shares in the last quarter. First Horizon Advisors Inc. acquired a new stake in shares of Tempus AI in the third quarter valued at approximately $30,000. Geode Capital Management LLC increased its holdings in shares of Tempus AI by 0.4% in the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock valued at $7,537,000 after purchasing an additional 539 shares in the last quarter. Operose Advisors LLC acquired a new stake in shares of Tempus AI in the fourth quarter valued at approximately $25,000. Finally, Prestige Wealth Management Group LLC increased its holdings in shares of Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after purchasing an additional 965 shares in the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.